Billionaire Launches Drug Company To Offer Low-Cost Versions Of High-Cost Drugs
January 28, 2021
Billionaire Mark Cuban has launched a generic drug company called the Mark Cuban Cost Plus Drug Company.
The company says it is dedicated to producing low-cost versions of high-cost generic drugs and pledges to "provide radical transparency in how we price our drugs."
The Cost Plus company will publish the costs to manufacture, distribute and market its drugs to pharmacies.
"We add a flat 15% margin to get our wholesale prices. This makes sure we remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug we make," the website states.
The first drug Cost Plus will produce is albendazole, an antiparasitic drug.
The company is hoping to introduce more than 100 drugs by the end of 2021, as well as build a pharmaceutical factory in Dallas by 2022.
"Our goal is that everyone should be able to afford their medicine," the company says.
"Everyone should know what it cost to make their medicine. Everyone should feel the price they paid for their medicine was fair."
Click Here For The Most Popular On Sunny Skyz
Football Player Asks Friend With Down Syndrome To Homecoming
Woman Is Late to Her Own Funeral After Hearse Keys Get Locked Inside
People Are Sharing Their Oddly Romantic Date Stories, And They’ll Make You Smile So Big
This Pit Bull Was Days Away From Being Euthanized. Now, He's A Police Hero
Hospital Staff Go Above And Beyond To Keep Couple’s 62-Year Anniversary Tradition Alive
Strangers Send Man Birthday Wishes At The Exact Minute His Late Mom Used To
Dad Dresses As Beast To Walk His Daughter to School And It’s Melting Hearts Everywhere
This Turkey Was Heartbroken — Until Her Owner Gave Her The Sweetest Surprise
Toddler’s 3 A.M. DJ Session Has the Internet Cracking Up
Man Compliments Elderly Strangers, Then Gives Them Flowers. Their Reactions Are So Wholesome
Flower Girl Drops Everything To Hug Her Favorite Uncle
